(RELX) Relx - Ratings and Ratios
Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US7595301083
RELX EPS (Earnings per Share)
RELX Revenue
RELX: Risk, Analytics, Legal, Science, Exhibitions, Data, Predictive Tools
RELX PLC is a global provider of information-based analytics and decision tools, serving professional and business customers across North America, Europe, and beyond. The companys diversified portfolio is organized into four key segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions, each catering to distinct customer needs and industries.
The Risk segment leverages public and industry-specific content, combined with advanced technology and algorithms, to help clients assess and predict risk. Meanwhile, the Scientific, Technical & Medical segment empowers researchers and healthcare professionals with critical information and data sets, driving scientific progress and improved health outcomes. The Legal segment delivers essential legal, regulatory, and business insights, enhancing customer decision-making and productivity. Lastly, the Exhibitions segment orchestrates face-to-face interactions, complemented by data and digital tools, facilitating market exploration, product sourcing, and transactions.
With a rich history dating back to 1903, RELX PLC has evolved from its former identity as Reed Elsevier PLC, rebranding in July 2015. Headquartered in London, the company has established itself as a stalwart in the Research & Consulting Services sub-industry, as classified by GICS. RELXs global presence and diversified offerings position it for sustained growth, driven by increasing demand for data-driven insights and decision-making tools.
Analyzing the provided
Forecasting RELXs future performance, we can anticipate potential price movements based on its technical and fundamental indicators. If the stock maintains its current momentum, it may test the resistance level near $55.66. Conversely, a decline could see it finding support around $47.9, $46.5, or lower at $45.0 and $42.7. Given the companys robust financials, diversified business segments, and the growing demand for its services, a bullish outlook seems plausible, potentially driving the stock towards its 52-week high or beyond.
Additional Sources for RELX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
RELX Stock Overview
Market Cap in USD | 97,342m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Research & Consulting Services |
IPO / Inception | 1994-10-07 |
RELX Stock Ratings
Growth Rating | 89.1 |
Fundamental | 88.7 |
Dividend Rating | 49.4 |
Rel. Strength | -1.86 |
Analysts | 4 of 5 |
Fair Price Momentum | 57.39 USD |
Fair Price DCF | 45.33 USD |
RELX Dividends
Dividend Yield 12m | 1.58% |
Yield on Cost 5y | 3.72% |
Annual Growth 5y | 5.19% |
Payout Consistency | 88.4% |
Payout Ratio | 58.7% |
RELX Growth Ratios
Growth Correlation 3m | 56.3% |
Growth Correlation 12m | 81.4% |
Growth Correlation 5y | 93.9% |
CAGR 5y | 20.15% |
CAGR/Max DD 5y | 0.77 |
Sharpe Ratio 12m | 0.32 |
Alpha | 9.48 |
Beta | 0.559 |
Volatility | 17.47% |
Current Volume | 749.6k |
Average Volume 20d | 801.5k |
As of June 27, 2025, the stock is trading at USD 53.31 with a total of 749,618 shares traded.
Over the past week, the price has changed by +2.30%, over one month by -4.22%, over three months by +7.80% and over the past year by +18.91%.
Yes, based on ValueRay´s Fundamental Analyses, Relx (NYSE:RELX) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 88.66 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RELX is around 57.39 USD . This means that RELX is currently overvalued and has a potential downside of 7.65%.
Relx has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy RELX.
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, RELX Relx will be worth about 63.8 in June 2026. The stock is currently trading at 53.31. This means that the stock has a potential upside of +19.71%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 56.5 | 5.9% |
Analysts Target Price | 56.5 | 5.9% |
ValueRay Target Price | 63.8 | 19.7% |